Workshop reports from the Third Asia-Pacific Regional Meeting of the International Working Group on Harmonization of Dementia Drug Guidelines

被引：0
|
作者：
Morris, John C.
Cummings, Jeffrey L.
机构：
[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63108 USA
[2] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA
来源：
ALZHEIMER DISEASE & ASSOCIATED DISORDERS | 2006年 / 20卷 / 04期
关键词：
D O I：
10.1097/01.wad.0000213868.94558.10
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：313 / 313
页数：1
相关论文
共 44 条
  • [1] Harmonization of dementia drug guidelines (United States and Europe): A report of the International Working Group for the Harmonization for Dementia Drug Guidelines
    Whitehouse, PJ
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2000, 14 : S119 - S122
  • [2] Report of the International Working Group on Harmonization of Dementia Drug Guidelines - Introduction
    Whitehouse, PJ
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 1 - 1
  • [3] Information technology and the International Working Group on Harmonization of Dementia Drug Guidelines
    Harvey, RJ
    Sciulli, CG
    Mason, RM
    Whitehouse, PJ
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 29 - 32
  • [4] The International Working Group on Harmonization of Dementia Drug Guidelines: Past, present, and future
    Whitehouse, PJ
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 2 - 5
  • [5] Ethical issues in dementia drug development - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Post, SG
    Beerman, B
    Brodaty, H
    Gaines, AW
    Gauthier, SG
    Geldmacher, DS
    Hill, S
    Homma, A
    Rossor, MN
    Whitehouse, PJ
    Winblad, B
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 26 - 28
  • [6] Clinical global measures of dementia - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Reisberg, B
    Schneider, L
    Doody, R
    Anand, R
    Feldman, H
    Haraguchi, H
    Kumar, R
    Lucca, U
    Mangone, CA
    Mohr, E
    Morris, JC
    Rogers, S
    Sawada, T
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 8 - 18
  • [7] Issues in the economic evaluation of treatment for dementia - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Winblad, B
    Hill, S
    Beermann, B
    Post, SG
    Wimo, A
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 39 - 45
  • [8] Diagnostic criteria for dementia in clinical trials - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Antuono, P
    Doody, R
    Gilman, S
    Huff, J
    Scheltens, P
    Ueda, K
    Khachaturian, ZS
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 22 - 25
  • [9] Length of clinical trials of dementia drugs - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Levy, R
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 33 - 33
  • [10] Quality-of-life assessment in dementia drug development - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Whitehouse, PJ
    Orgogozo, JM
    Becker, RE
    Gauthier, S
    Pontecorvo, M
    Erzigkeit, H
    Rogers, S
    Mohs, RC
    Bodick, N
    Bruno, G
    DalBianco, P
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 56 - 60
12345